Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
The Journal of Urology|October 18, 2016
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for CystoscopyKim E M van Kessel, Willemien Beukers, Irene Lurkin, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 4, 2024
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder CancerJoep J de Jong, Florus C de Jong, Angelique C J van der Made, et al.
European Urology|July 22, 2010
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancerBas W G van Rhijn, Tahlita C M Zuiverloon, André N Vis, et al.
Gynecologic Oncology|March 17, 2015
Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometriumYvette P Geels, Louis J M van der Putten, Angela A G van Tilborg, et al.
BJU International|March 28, 2012
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancerBas W G van Rhijn, Liyang Liu, André N Vis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2014
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classificationsBas W G van Rhijn, Mireia Musquera, Liyang Liu, et al.
The Journal of Urology|January 28, 2020
A Urine Based Genomic Assay to Triage Patients with Hematuria for CystoscopyKim E M van Kessel, Joep J de Jong, Angelique C J Ziel-van der Made, et al.
Molecular Oncology|September 8, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancerGeertje van der Horst, Arjanneke F van de Merbel, Eline Ruigrok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2016
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center StudyMaria Frantzi, Kim E van Kessel, Ellen C Zwarthoff, et al.
Pageof 12